SCHEMBL8764112

SCHEMBL8764112

O=C(O)CCCNNCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
TSHR P16473 3/20 0.46
NFKB1 P19838 2/20 0.46
PMP22 Q01453 1/20 0.46
PRMT1 Q99873 1/20 0.43
CAMK2A Q9UQM7 1/20 0.42
ADRA1A P35348 1/20 0.40
GABRR3 A8MPY1 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
HDAC3 O15379 1/20 0.40
GABBR2 O75899 1/20 0.40
CYP1A2 P05177 1/20 0.40
THRB P10828 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRR1 P24046 1/20 0.40
GABRB3 P28472 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015864 0.84 LMNA (0.53) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL13657827 0.79 TSHR (0.67) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL288365 0.79 LMNA (0.53) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL20240413 0.78 AKR1B1 (0.48) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL15871536 0.78 ALOX15 (0.46) SLC22A6TSHRHDAC3KMT2AHDAC11
SCHEMBL8352247 0.78 LDHA (0.50) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL11113527 0.77 LMNA (0.50) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL28310136 0.76 EPHX1 (0.46) SLC22A6TSHRKMT2AHDAC11GPR84
SCHEMBL24570655 0.75
SCHEMBL15844118 0.75 PRMT1 (0.34) PRMT1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784628-A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1997-07-23 EP disclosed
EP-0749429-A1 3,5-DISUBSTITUTED AND 3,5,6-TRISUBSTITUTED 2-ISOXAZOLINES AND ISOXAZOLES, PROCESS FOR PREPARING THE SAME AND THEIR USE AS MEDICAMENTS HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-27 EP disclosed
WO-1995035308-A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-12-28 WO disclosed
WO-1995024397-A1 3,5-DISUBSTITUTED AND 3,5,6-TRISUBSTITUTED 2-ISOXAZOLINES AND ISOXAZOLES, PROCESS FOR PREPARING THE SAME AND THEIR USE AS MEDICAMENTS HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-14 WO disclosed